Edition:
United States

Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

189.32USD
18 Aug 2017
Change (% chg)

$-1.88 (-0.98%)
Prev Close
$191.20
Open
$190.74
Day's High
$191.27
Day's Low
$189.17
Volume
374,094
Avg. Vol
370,979
52-wk High
$199.89
52-wk Low
$119.37

ILMN.OQ

Chart for ILMN.OQ

About

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of... (more)

Overall

Beta: 0.78
Market Cap(Mil.): $27,697.52
Shares Outstanding(Mil.): 146.30
Dividend: --
Yield (%): --

Financials

  ILMN.OQ Industry Sector
P/E (TTM): 37.30 118.44 32.56
EPS (TTM): 5.07 -- --
ROI: 18.76 9.54 14.89
ROE: 31.34 14.77 16.13

'Liquid biopsy' spots early-stage cancers in blood: U.S. study

CHICAGO A test that scans blood for tumor-specific DNA identified early-stage cancer in more than half of 138 patients with the disease, U.S. researchers reported on Wednesday, marking a new milestone in the rush for so-called "liquid biopsies."

Aug 16 2017

'Liquid biopsy' spots early-stage cancers in blood -U.S. study

CHICAGO, Aug 16 A test that scans blood for tumor-specific DNA identified early-stage cancer in more than half of 138 patients with the disease, U.S. researchers reported on Wednesday, marking a new milestone in the rush for so-called "liquid biopsies."

Aug 16 2017

Illumina shares sparkle on strong demand for new gene tech

Shares of Illumina Inc surged nearly 14 percent on Wednesday, a day after the company raised its 2017 revenue forecast on strong demand for its new gene-sequencing technology.

Aug 02 2017

CORRECTED-UPDATE 1-Illumina shares sparkle on strong demand for new gene tech

Aug 2 Shares of Illumina Inc surged nearly 14 percent on Wednesday, a day after the company raised its 2017 revenue forecast on strong demand for its new gene-sequencing technology.

Aug 02 2017

Illumina shares sparkle on demand for new gene tech

Aug 2 Shares of Illumina Inc surged nearly 12 percent on Wednesday, a day after the company raised its full-year revenue forecast on higher-than-expected demand for its new gene-sequencing technology.

Aug 02 2017

BRIEF-Illumina Q2 earnings per share $0.87

* Illumina reports strong financial results for second quarter of fiscal year 2017

Aug 01 2017

Illumina notches win in prenatal testing patent fight

A federal appeals court on Tuesday revived a patent on fetal diagnostic testing that Illumina Inc has accused rival Sequenom Inc of infringing.

Jun 27 2017

BRIEF-Inno-Gene says units reach agreement with Illumina over patent dispute

* SAID ON FRIDAY THAT ITS UNITS, CENTRUM BADAN DNA SP. Z O.O AND MEDGENETIX SP. Z O.O., REACHED SETTLEMENT WITH THE COMPANY ILLUMINA INC. CONCERNING VIOLATION OF INTELLECTUAL PROPERTY OF ITS PATENT

Jun 26 2017

BRIEF-HTG Molecular amends, restates IVD test development, component supply agreement with Illumina

* Amended and restated its IVD test development and component supply agreement with Illumina

Jun 05 2017

BRIEF-Illumina reports Q1 GAAP earnings per share $2.52

* Illumina reports financial results for first quarter of fiscal year 2017

Apr 25 2017

Earnings vs. Estimates